1. Home
  2. ASUR vs ABOS Comparison

ASUR vs ABOS Comparison

Compare ASUR & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asure Software Inc

ASUR

Asure Software Inc

HOLD

Current Price

$8.86

Market Cap

224.4M

Sector

Technology

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.15

Market Cap

182.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASUR
ABOS
Founded
1985
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.4M
182.0M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
ASUR
ABOS
Price
$8.86
$2.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$14.33
$8.00
AVG Volume (30 Days)
79.6K
300.2K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$88,952,000.00
N/A
Revenue This Year
$16.33
N/A
Revenue Next Year
$9.20
N/A
P/E Ratio
$455.00
N/A
Revenue Growth
63.39
N/A
52 Week Low
$6.80
$1.05
52 Week High
$11.47
$3.60

Technical Indicators

Market Signals
Indicator
ASUR
ABOS
Relative Strength Index (RSI) 49.20 36.08
Support Level $8.81 $1.85
Resistance Level $9.74 $2.42
Average True Range (ATR) 0.41 0.15
MACD 0.02 -0.02
Stochastic Oscillator 48.88 9.50

Price Performance

Historical Comparison
ASUR
ABOS

About ASUR Asure Software Inc

Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: